MEDIUM confidence: 100% data completeness, but the composite (49) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.3B— | $3.3B+42.8% | $3.5B+7.4% | $3.2B-8.0% | $3.2B-1.4% |
| EPS (dil.) | $3.00— | $1.46-51.3% | $1.20-17.8% | $1.93+60.8% | $1.55-19.7% |
| Free Cash Flow | $190M— | -$103M-154.3% | $188Mn/m | $316M+68.5% | $396M+25.3% |
| Gross Margin | 46.1% | 42.5%-3.5pp | 42.5%-0.0pp | 45.9%+3.4pp | 44.4%-1.5pp |
| Operating Margin | 24.0% | 14.6%-9.4pp | 14.2%-0.5pp | 16.5%+2.3pp | 28.9%+12.4pp |
| Net Margin | 17.8% | 6.4%-11.4pp | 5.1%-1.2pp | 9.0%+3.9pp | 7.4%-1.7pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $181 (last qtr, 8 analysts) → $187 (last mo, 4) (+3.1%).
Buy-rated share 55% → 58% over ~3 months (+4pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $0.82 | $0.93 | +13.1% |
| Apr 2026 | $0.74 | $0.86 | +15.4% |
| Feb 2026 | $0.67 | $0.70 | +4.9% |
| Oct 2025 | $0.72 | $0.72 | +0.0% |
| Jul 2025 | $0.65 | $0.66 | +2.3% |
| May 2025 | $0.68 | $0.67 | -1.8% |
| Feb 2025 | $0.77 | $0.84 | +9.1% |
| Nov 2024 | $0.78 | $0.77 | -1.2% |
Net insider -$32.7M over 180 days (0 open-market buys, 26 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 8.4%/yr (revenue basis).
Base free cash flow $300M (avg FY2023–FY2025; latest year $396M) · equity value $24.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 49 for Entegris indicates a neutral outlook, with the stock's strong momentum being offset by concerns around value and growth. Entegris scores high on momentum, driven by a 113.4% return over the past year, but trades at a premium with a P/E of 81.5x, contributing to a lower value score. The company exhibits strong profitability metrics, including a gross margin of 45.5%, but growth has been sluggish, with revenue and EPS declining by 1.4% and 20.1%, respectively. The long-term and short-term scores are relatively close, with the short-term score 5 points higher.